Vanderbilt begins phase 1 trials of new Alzheimer’s drug

Written By Alex tapper

Research News @ Vanderbilt

Alex tapper

Just here to help out.

Previous

VCNDD drug candidate enters clinical trials at Vanderbilt.
Next

Academic drug discovery centers adapt to shifts in funding sources